论文部分内容阅读
目的:为实施乳腺癌规范治疗,提高医疗质量,改善患者生存质量,节约医疗成本,降低乳腺癌患者医疗费用,进行乳腺癌的临床经济学评价。方法:对江苏省肿瘤医院2003年1月～2007年9月收治的1164例乳腺癌住院患者(非规范综合治疗1036例,规范治疗128例)的病例资料及费用明细数据进行回顾性分析和最小成本法分析。结果:非规范与规范的乳腺癌综合治疗患者平均住院天数为60.59天和39.84天;平均住院次数为3.77次与2.52次;平均住院总费用分别为54863.27元和33426.71元,均有显著性差异。结论:乳腺癌综合治疗费用较高,实施规范治疗后,住院天数、住院次数和平均住院总费用均降低;相同临床治疗效果下,规范治疗比非规范治疗要好。可见,规范治疗在临床经济学上更可行,且具有较好的推广应用价值。
OBJECTIVE: To evaluate the clinical economics of breast cancer by implementing standardized treatment of breast cancer, improving medical quality, improving patients’ quality of life, saving medical costs, reducing medical costs for breast cancer patients. Methods: A retrospective analysis of 1164 cases of inpatients with breast cancer (1036 cases of unconventional comprehensive treatment and 128 cases of normative treatment) admitted to Jiangsu Tumor Hospital from January 2003 to September 2007 was retrospectively analyzed and the minimum cost Cost Analysis. Results: The average hospitalization days for patients with non-normative breast cancer treatment were 60.59 days and 39.84 days respectively. The average number of hospitalizations was 3.77 times and 2.52 times. The average cost of hospitalization was 54863.27 yuan and 33426.71 yuan, respectively, with significant differences. Conclusion: The cost of comprehensive treatment of breast cancer is high. After the implementation of standardized treatment, the number of hospitalization days, hospitalization and average hospitalization costs are reduced. Under the same clinical treatment effect, standardized treatment is better than non-standard treatment. Can be seen that standard treatment is more feasible in clinical economics, and has a good promotion and application value.